GlassScriptPhysician profile
Daniel B Spagnoli
NPI 1679547350
$4,731.73
in general payments reported to CMS, 2019-2025
14 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $177 · 2021: $3,244 · 2022: $158 · 2023: $361 · 2024: $45.55 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $606.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $3,627.70 | 2019-2023 | Biohorizons |
| Arteriocyte Medical Systems, INC. | $131.22 | 2025 | Magellan |
| Salvin Dental Specialties, INC. | $131.03 | 2019 | |
| Stryker Corporation | $121.44 | 2020 | |
| Dentsply Sirona INC | $115.86 | 2021-2024 | Astra Tech Implant System, Consumable Dentistry |
| Kls-Martin L.P. | $111.11 | 2023 | |
| Keystone Dental INC. | $110.58 | 2019 | |
| Medtronic USA, INC. | $109.73 | 2019 | |
| Geistlich Pharma, North America, INC. | $94.11 | 2021-2025 | Biomaterials |
| Straumann USA LLC | $78.99 | 2022-2023 | |
| Southern Implants North America INC | $45.23 | 2020-2021 | |
| Kulzer, LLC | $28.93 | 2023 | |
| Henry Schein, INC. | $14.72 | 2024 | |
| Galderma Laboratories, L.P. | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Spagnoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.